Kanghua Biological released its performance for the first half of the year, with a net profit attributable to the parent company of 115 million yuan, a year-on-year decrease of 62.64%
Kanghua Biological released its 2025 semi-annual report, with operating revenue of 484 million yuan, a year-on-year decrease of 34.70%; net profit attributable to the parent company of 115 million yuan, a year-on-year decrease of 62.64%; net profit excluding non-recurring gains and losses of 112 million yuan, a year-on-year decrease of 63.88%; basic earnings per share of 0.8813 yuan
According to the Zhitong Finance APP, Kanghua Biological (300841.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 484 million yuan, a year-on-year decrease of 34.70%. The net profit attributable to shareholders of the listed company was 115 million yuan, a year-on-year decrease of 62.64%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 112 million yuan, a year-on-year decrease of 63.88%. The basic earnings per share were 0.8813 yuan
